Ventricular fibrillation (VF) is one of the most lifethreatening cardiac events. It accounts for a large number of human mortalities and, if survived, is a common cause of debility due to accompanying brain damage. Until now, it is widely believed that VF does not cease spontaneously and that electric shock is mandatory to revert it. However, there is growing evidence to prove that VF can also regress spontaneously to sinus rhythm [1] . The available reports indicate that there are two types of VF, first, sustained VF requiring electrical defibrillation and secondly, transient VF that spontaneously reverts to sinus rhythm without electrical defibrillation.
phenomenon of rodents and small mammals [1] . The findings that it appears also in puppies [3] and human beings opposed this postulation.
Drug induced transformation of sustained into transient VF
There is a common agreement that Ca 2+ overload is involved in the triggering of sustained VF [8, 9] . Studies carried out on various experimental animals showed that self ventricular defibrillation requires high level of intercellular coupling and synchronization [2, 10] that depends on [Ca 2+ ]i [8] . Elevation of [Ca 2+ ]i may cause cell to cell uncoupling and inhibition of intercellular communication [11, 12] . Deterioration of myocardial intercellular synchronization may increase the number of the fibrillating micro-areas [13] . It allows VF to sustain [9] and decreases the ability of the heart to defibrillate spontaneously [10] .
Ttreatment of adult mammals, normally exhibiting sustained VF, with compounds that decrease [Ca 2+ ]i caused transformation of sustained VF into transient VF [14] [15] [16] [17] . These defibrillating agents are likely to enhance the activity of the Ca 2+ -ATPase SERCA2, which sequesters Ca 2+ into the sarcoplasmic reticulum. Following these finding we pointed out [18] 
SERCA 2a activity and cardiac myosin heavy chain isoforms
The mammalian myocardium expresses up to three myosin heavy chain (MHC) isoforms that differ in their ATPase activity [19] . The MHC protein that moves fastest during electrophoresis on pyrophosphate gels, is the ␣-␣ MHC homodimer (designated V1) and has the highest ATPase activity, whereas the slow moving isoform ␤-␤ MHC (or V3) has the lowest ATPase activity. The third isoform V2 is a heterodimer composed of one ( and one ( monomer (␣-␣ MHC), with intermediate ATPase activity.
In Table 1 , we noticed that a correlation existed between the type of VF and the respective expression of the cardiac myosin heavy chain (MHC) isoform profile [20] . Following this comparison we have suggested that:
Transient VF is a feature of mammals with predominant V1 myocardial MHC, which is known to be associated with a high level of SERCA 2a activity, (young and old rats as well as young guinea pigs, rabbits, cats and puppies). Secondly, transient VF is not observed in mammals that express only the cardiac MHC isoform V3, or associated with a very low level of SERCA 2a activity (newborn rats and guinea pigs and adult dogs and pigs). Thirdly, transient VF can be facilitate in mammals with low V1 myocardial MHC (adult guinea pigs, rabbits, cats and young piglets) by treatment with some 'defibrillating' compounds that increase SERCA 2a activity.
How to promote transient VF
It was found that the occurrence of transient VF can be promoted in mammals (adult guinea pigs, rabbits and cats and piglets) by acute treatment with `defibrillating' compounds such as tricyclic antidepressants (e.g. dibenzepin) [21] that are thought to decrease intracellular Ca 2+ overload or with other defibrillating compounds like D-sotalol [16] or Tedisamil [17] that likely enhance SERCA 2a activity and decrease [Ca 2+ ]i .
Although the appearance of transient VF in human beings is still a matter of controversy [22] , there are reported cases of drug-induced defibrillation in human beings [23] . The question arises whether the occurrence of transient VF in human beings can also been explained by preferential expression of V1 and associated high level of SERCA 2a activity. Support for this comes from the findings of Gorsa et al. [24] that the amount of V1 isomyosin differs among human ventricles with a mean value around 33% of total MHC. More over, in some cases, V1 was found to be even the major cardiac isoform [23] .
It is obvious that the mechanisms of VF remain a challenge, for both clinicians and basic science cardiologists, and some other new mechanisms might be (re)considered in the future, e.g. inward rectifying potassium current (IK1) [25] , interstitial Cajal-like cells [26] or Brugada syndrome [27] .
Conclusions
The available findings imply that Ca 2+ overload is the key event in the appearance and sustaining of VF.
Decreasing intracellular Ca 2+ is likely to decrease the fibrillating rate and set the stage for spontaneous defibrillation. It follows that appropriate antiarrhythmic/ defibrillating compounds must have the ability to decrease [Ca 2+ ]i, e.g. by augmenting SERCA 2a pump activity stimulating Ca 2+ sequestration. We noticed that a correlation existed between the type of VF and the respective expression of their SERCA 2a activity.
Our experiments and those of others have shown that spontaneous ventricular defibrillation occurs in vivo and ex vivo and was not limited to animal experiments. There are reported cases of spontaneous or drug induced ventricular defibrillation in human being that, although rare, cannot be considered anecdotal. These findings can encourage research looking for safe and efficient defibrillating antiarrhythmic drugs for preventing sudden cardiac death due to VF in human beings unprotected by implantable cardioverter defibrillator (ICD). Such drugs can even decrease the number of electrical shocks and significantly improve the quality of life patients with ICD. [20] .
